Upgrade Your Subscription

BioCentury helps biotech professionals and investors make business-critical decisions by providing independent deep-dive analysis, high-quality data, and business intelligence on a global scale. No matter where you are in the drug development process—from idea to patient—we help you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks.

Does your organization currently have a subscription and you need assistance? Please contact our support team.

Going from Publications + Archives-only to Publications + Archives + BCIQ
Take your intelligence further. Your analysis, now backed by the data behind it.

You're already using BioCentury Analysis. Unlock the full depth of our platform with BCIQ. Go from reading about a deal or pipeline move to interrogating the full dataset behind it, in seconds.

What You're Adding
You've been using BioCentury to follow the science, the deals, and the strategy. BCIQ gives you the structured database layer that sits underneath all of it, so you can search, filter, and analyze rather than just read.

• Pipeline Database: Go beyond reading about a drug program — pull every asset in an indication, filter by stage, modality, or mechanism, and export to your own models. 20,000+ programs tracked globally.
• Deal Comps: When you read about a licensing deal in your Analysis feed, BCIQ lets you benchmark it instantly. Search structured deal terms across hundreds of comparable transactions.
• Asset & Company Profiles: Every company and drug program has a structured profile — financials, pipeline, partners, and history — all in one place, always current.
• Custom Watchlists: Build and save screens around the companies, targets, or indications you care about. Get notified when something changes.